Mineralys Therapeutics, Inc.

NASDAQ:MLYS

Biotechnology

Healthcare
$14.16 +1.49%

+$0.37 today

Market cap
$1.25B
Beta
0.56
P/E (TTM)
-13.9
EPS (TTM)
-$1.83
52W Low $12.59High $47.65

Volume 1.17M

Average 1.48M

Private 5-step workspace

Build a MLYS investment thesis

Turn Mineralys Therapeutics, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.